The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...

Firstly thank you Amazon for restocking VU after months.Really liked the whole packaging and product.Build quality is excellent with bezelless design.It comes with wall mount and it's easy to install ...

I round up the best Micro Four Thirds lenses, from ultra-wide angle to super-telephoto and everything in between. I'm an avowed enthusiast of the system, having used Olympus and OM System gear in my ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Server maker Super Micro Computer stock (NASDAQ: SMCI) has moved largely sideways in 2025, trading at about $31 per share currently. The stock experienced considerable volatility in 2024 ...

The most recent trading session ended with Super Micro Computer (SMCI) standing at $31.12, reflecting a +0.42% shift from the previouse trading day's closing. The stock outperformed the S&P 500 ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program that the HHS claims violates anti-kickback statutes. In a court filing on ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the ...